News
Maruti and Cipla trade below long-term P/E averages. Both show solid fundamentals, but growth has slowed. Execution on new ...
Q3 2025 Earnings Call Transcript May 1, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.35, ...
In the fifth part of our series on Q4FY25 earnings, we examine the gradual improvement in profit margins across India Inc., ...
Just as a new growth phase seemed to be inching closer, European manufacturing is now facing a new era of trade turmoil. A ...
Results: Today, majors like Vedanta, Adani Power, IOCL, Indus Towers, Varun Beverages, Jindal Steel & Power, JSW ...
President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the ...
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...
But drugmakers are already bracing for those pharmaceutical-specific levies as they grapple with evolving trade policy, with ...
As U.S. and China relations remain tense, concerns are growing over America’s deep reliance on China for critical ...
Most appealing to long-term investors is that Pfizer stock is trading near its decade-long low in terms of price to forward earnings at 7.7X and well below the high of 20.1X during this period. PFE ...
Fibmold upcycles plant fibers from ag waste into molded fiber packaging to help partners reduce their reliance on single use ...
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results